Acid-Responsive Transferrin Dissociation and GLUT Mediated Exocytosis for Increased Blood-Brain Barrier Transcytosis and Programmed Glioma Targeting Delivery-Reference-Cited by-同舟云学术

Acid-Responsive Transferrin Dissociation and GLUT Mediated Exocytosis for Increased Blood-Brain Barrier Transcytosis and Programmed Glioma Targeting Delivery

Published:2018-05-28 Issue:30 Volume:28 Page:1802227
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Ruan Shaobo¹,Qin Lin¹,Xiao Wei¹,Hu Chuan¹,Zhou Yang¹,Wang Ranran¹,Sun Xing¹,Yu Wenqi¹,He Qin¹,Gao Huile¹^ORCID

Affiliation:

1. Key laboratory of Drug Targeting and Drug Delivery Systems; West China School of Pharmacy; Sichuan University; Chengdu 610041 China

Funder

National Natural Science Foundation of China

China Association for Science and Technology

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Reference53 articles.

1. Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerations

2. Structure and function of the blood–brain barrier

3. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors

4. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging

5. Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy;Biomaterials;2024-12

2. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma;Biomaterials;2024-12

3. Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma;Exploration;2024-06-26

4. Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma;ACS Nano;2024-06-11

5. Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells;Pharmaceutics;2024-06-08